Peter Rossing Selected Research

Kidney Diseases (Kidney Disease)

4/2024	Combination therapy for kidney disease in people with diabetes mellitus.
1/2024	Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes.
12/2023	Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex.
12/2023	Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
1/2023	HbA1c and beyond.
1/2023	Sotagliflozin, a dual sodium-glucose co-transporter-1 and sodium-glucose co-transporter-2 inhibitor, reduces the risk of cardiovascular and kidney disease, as assessed by the Steno T1 Risk Engine in adults with type 1 diabetes.
1/2023	Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study.
1/2023	Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis.
2/2022	Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis.
1/2022	Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Rossing Research Topics

Disease

195	Type 2 Diabetes Mellitus (MODY) 05/2024 - 03/2004
120	Albuminuria 03/2024 - 07/2002
118	Chronic Renal Insufficiency 05/2024 - 07/2008
99	Diabetic Nephropathies (Diabetic Nephropathy) 05/2024 - 07/2002
81	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2024 - 05/2002
54	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 10/2004
47	Heart Failure 05/2024 - 03/2012
34	Renal Insufficiency (Renal Failure) 05/2024 - 05/2019
29	Kidney Diseases (Kidney Disease) 04/2024 - 07/2009
28	Inflammation (Inflammations) 02/2024 - 12/2006
28	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 09/2004
17	Disease Progression 02/2024 - 07/2008
17	Hyperkalemia 12/2023 - 12/2005
16	Hypertension (High Blood Pressure) 03/2024 - 07/2009
15	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 11/2010
14	Stroke (Strokes) 12/2023 - 10/2012
13	Body Weight (Weight, Body) 01/2024 - 01/2008
12	Diabetes Mellitus 04/2024 - 01/2015
12	Fibrosis (Cirrhosis) 02/2024 - 11/2010
10	Obesity 03/2024 - 03/2017
9	Myocardial Infarction 02/2024 - 12/2018
9	Diabetes Complications 01/2023 - 03/2013
8	Heart Diseases (Heart Disease) 01/2023 - 08/2011
8	Proteinuria 01/2021 - 03/2004
7	Weight Loss (Weight Reduction) 10/2023 - 11/2015
7	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023 - 10/2004
6	Atherosclerosis 01/2021 - 08/2011
5	Insulin Resistance 12/2023 - 01/2017
5	Infections 01/2021 - 12/2019
4	Neoplasms (Cancer) 01/2023 - 01/2017
3	Eye Diseases (Eye Disease) 10/2023 - 11/2022
3	Vitamin D Deficiency 10/2023 - 05/2011

Drug/Important Bio-Agent (IBA)

81	AlbuminsIBA 02/2024 - 05/2002
75	CreatinineIBA 02/2024 - 10/2004
65	Biomarkers (Surrogate Marker)IBA 05/2024 - 12/2006
44	dapagliflozinIBA 05/2024 - 01/2019
44	finerenoneIBA 04/2024 - 01/2014
36	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2009
26	Mineralocorticoid Receptor AntagonistsIBA 04/2024 - 01/2014
22	Liraglutide FDA Link 09/2023 - 04/2015
21	SodiumIBA 04/2024 - 12/2018
21	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2024 - 12/2018
20	Sodium-Glucose Transport ProteinsIBA 02/2024 - 12/2018
18	Insulin (Novolin)FDA Link 09/2023 - 01/2008
15	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 05/2002
15	Losartan (Cozaar)FDA LinkGeneric 01/2017 - 07/2002
13	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2024 - 07/2015
13	LipidsIBA 01/2024 - 02/2015
13	empagliflozinIBA 01/2024 - 11/2019
12	Proteins (Proteins, Gene)FDA Link 05/2024 - 02/2010
12	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2024 - 01/2020
12	CalciumIBA 01/2023 - 08/2011
12	pro-brain natriuretic peptide (1-76)IBA 11/2022 - 08/2011
12	Irbesartan FDA LinkGeneric 01/2016 - 03/2004
11	ProteomeIBA 02/2024 - 07/2008
11	Uric Acid (Urate)IBA 11/2022 - 07/2009
10	Peptides (Polypeptides)IBA 03/2024 - 01/2008
10	omega-Chloroacetophenone (Mace)IBA 03/2024 - 01/2020
10	Angiotensin Receptor AntagonistsIBA 12/2023 - 07/2002
9	AldosteroneIBA 03/2024 - 12/2005
9	CholesterolIBA 01/2021 - 03/2003
8	CollagenIBA 03/2024 - 11/2010
8	Spironolactone (Aldactone)FDA LinkGeneric 02/2023 - 12/2005
7	semaglutideIBA 03/2024 - 11/2020
7	PotassiumIBA 02/2023 - 12/2005
7	aliskiren FDA Link 10/2013 - 10/2009
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2023 - 05/2003
6	Urokinase Plasminogen Activator ReceptorsIBA 11/2023 - 06/2016
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2023 - 09/2005
6	Hemoglobins (Hemoglobin)IBA 01/2022 - 10/2004
5	Glucagon-Like Peptide-1 ReceptorIBA 01/2024 - 07/2015
5	Triglycerides (Triacylglycerol)IBA 10/2023 - 01/2016
5	SymportersIBA 01/2022 - 05/2019
5	Angiotensin IIIBA 12/2021 - 08/2002
5	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2021 - 07/2010
5	Metformin (Glucophage)FDA LinkGeneric 08/2021 - 01/2008
5	C-Reactive ProteinIBA 01/2021 - 01/2013
5	AdiponectinIBA 01/2016 - 08/2008
5	Vitamin D FDA LinkGeneric 10/2013 - 10/2010
5	Advanced Glycation End ProductsIBA 11/2011 - 12/2006
4	Endothelin Receptor AntagonistsIBA 04/2024 - 11/2021
4	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 03/2024 - 01/2020
4	ReninIBA 01/2024 - 11/2008
4	Cystatin CIBA 12/2023 - 06/2014
4	Telmisartan (Micardis)FDA Link 11/2023 - 02/2005
4	N 30IBA 01/2023 - 11/2009
4	AtrasentanIBA 01/2023 - 10/2020
4	Atrial Natriuretic Factor (ANF)IBA 10/2020 - 01/2017
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 09/2005
4	Connective Tissue Growth FactorIBA 01/2015 - 06/2005
4	Edetic Acid (EDTA)FDA Link 04/2008 - 08/2002
3	Complement System Proteins (Complement)IBA 03/2024 - 10/2014
3	EnzymesIBA 01/2024 - 06/2005
3	LinagliptinIBA 11/2023 - 01/2023
3	baricitinibIBA 11/2023 - 01/2023
3	CeramidesIBA 10/2023 - 01/2023

Therapy/Procedure

53	Therapeutics 05/2024 - 03/2004
11	Glycemic Control 01/2023 - 12/2006
4	Transplantation 01/2022 - 09/2004
3	Precision Medicine 12/2023 - 01/2019